Creating and Using Benchmarks



Creating and Using Benchmarks






Science is facts; just as houses are made of stones, so is science made of facts; but a pile of stones is not a house and a collection of facts is not necessarily science.

–Henri Poincare


There are in fact two things, science and opinion; the former begets knowledge, the latter ignorance.

–Hippocrates (460-377 BC).


WHAT ARE BENCHMARKS?

Benchmarks are measurements that an individual or organization can use to assess performance. They can be determined within an organization (internal benchmarks) or as an average or range for a group of organizations (external benchmarks) in order to allow comparisons between different points in time. Benchmarks are an attempt to promote “organizational learning” by determining the time it took to accomplish a task or the parameters that were present to complete a project successfully. Organizations establish benchmarks as a roadmap of what development teams should attempt to do and not to do in order to increase success and minimize risk. The activities measured range along a spectrum from those that are well established and used to guide an organization to informal ones chosen as standards by a few people for the same purpose. Benchmarks may be created from data obtained from several or many companies, and some people view them as industry-wide standards. However, although some benchmarks are standards, many are not. Internal company benchmarks may be used as measures of progress or possibly of success in an activity within the company. These benchmarks usually illustrate results of a specific activity measured over a period of time, often one to five years.

The items benchmarked may be large and broad activities, such as the time required for synthetic work to create a chemical lead or project compound, time required for all advanced screening activities on a chemical lead compound, or time to first marketing submission from the first Investigational New Drug Application, or smaller issues, such as the time for protocol preparation, protocol review and approval, Institutional Review Board approval from time of submission, or completion of statistical analyses from the time of database lock. Many other benchmarks are listed later in this chapter.

Benchmarks may be based on data collected over any length of time, up to decades, and may be presented in many ways, such as numbers of specific activities expressed on a per
professional basis, as annual numbers, or as annual numbers calculated on a rolling average. Benchmarks may also represent subjective opinions of a few or many people, rather than being derived from objective quantitative data (i.e., the benchmark can be based on what “experts” believe a company or group should accomplish rather than being based on the average of what a group of companies actually accomplishes). While not widely used, subjective benchmarks could be the basis of how a company determines its own goals. The groups or companies contributing objective data to create an industry benchmark may be independent organizations, or they may all be part of the same parent company.


EXAMPLES OF PHARMACEUTICAL INDUSTRY BENCHMARKS

There are a large number of potential parameters to measure if one’s goal is to enumerate activities and behaviors that can be benchmarked. A few examples of benchmarks are given in the following sections as illustrations. Almost all of these can be viewed on an internal basis to evaluate an individual’s and a company’s performance from year to year and to judge if it has achieved the goals set the preceding year or the goals based on comparisons with other companies. If the latter comparison is desired, the underlying assumption is that the average of the companies contributing data to the group that collects them is accurate and the data are meaningful to use as a comparison (i.e., one is comparing similar or identical categories of data). It must be stressed that the author does not endorse many of these measures as relevant benchmarks to assess, but they have been used by various companies and are, therefore, listed. A company can create a goal for most of these or other benchmarks and track their progress on a periodic (usually annual) basis and then initiate or modify activities to assist the company’s efforts to achieve these goals. Alternatively, it can merely attempt to surpass the median or mean industry value for a selection of benchmarks if it has data that it believes are valid.


Corporate Benchmarks



  • Amount of money (revenue) per employee per year (of course, it is important to also focus on the amount of profit versus sales; if you sell a million $10 units at a loss of $1 each, you should not focus on the sales of $10 million but on the loss of $1 million)


  • Percent of sales obtained on drugs initially introduced on the market within the past five years


  • Number of Investigational New Drug Applications submitted per year


  • Number of New Drug Applications (NDAs) submitted (or approved) per year (calculated on a three-year rolling average)


  • Number of patents submitted per year


  • Number of products licensed-in per year


Data Management Benchmarks



  • Number of days to resolve a question


  • Number of keystrokes per data entry operator per hour


  • Number or errors per thousand keystrokes


  • Time to complete data listings after the database is locked


  • Time to generate a final medical report after the database is locked


Clinical Benchmarks



  • Number of adverse events managed per month


  • Number of clinical trials (or clinical trial sites) monitored by a Clinical Research Associate at any one time


  • Number of clinical protocols authored by a company physician per year


  • Time to complete the protocol’s draft


  • Time to review and approve a protocol


  • Number of protocol amendments


  • Time to obtain clinical trial material from the time it is ordered


  • Time to dose the first patient after the Institutional Review Board has approved the protocol at a site


  • Number of patients recruited per month


  • Number of trials analyzed per year by a senior statistician


  • Number of days from the completion of the last patient in a trial until the database is closed


  • Time to complete the medical report from the time the statistical analyses are completed (or from the time the statistical report is completed)


  • Costs of many components of a clinical trial


  • Time to achieve any of many other components of a clinical trial or program


Drug Development Benchmarks



  • Number of compounds synthesized per year


  • Number of compounds screened per year


  • Percentage of official projects that reach the NDA stage


  • Percentage of projects that fail at each stage of development


  • Number of NDAs approved per year


  • Costs of many components of a drug’s development


  • Time to achieve any of many components of a development program


Marketing Benchmarks



  • Number of physicians seen per day by each sales representative


  • Number of potential customers (e.g., nurses, pharmacists, physicians) seen per day by each sales representative


  • Amount of money (i.e., profits) generated per sales representative per month (year)


  • Time to launch a new drug, dosage form, or indication after regulatory approval is received


  • Time to reach peak market penetration after launch of a new product

Many additional examples of types of benchmarks can be found in this book, particularly in Chapters 21, 48, and 52. Chapter 52 illustrates and discusses many ways to view and assess a portfolio of products. These can be used as the basis of creating internal company benchmarks. Chapter 56 discusses numerous ways of measuring the success of projects. Almost all of the benchmarks are given in units of time or in numbers, both of which may be easily assessed in terms of meeting goals.

The author endorses creating most benchmarks using internal company data. Readers who seek industry-wide benchmarks can find a number of actual benchmark values in various trade publications and in data collected by national trade associations and certain academic groups such as the Tufts Center for the Study of Drug Development and in the organizations mentioned on the following pages.



APPLICATION OF BENCHMARKS

Achieving or surpassing accepted benchmarks could be a reasonable goal for a company that knows that it is not performing at the established benchmark level. For example, a company’s goal may be to have all data entered into a database three weeks after a clinical trial is completed, but the company’s current level of performance is that it achieves this activity in seven weeks, and the industry average (i.e., benchmark) may be five weeks.


Application of Benchmarks to Macro or Micro Activities

Benchmarks are often broad goals [e.g., a pharmaceutical company with sales of X and a staff of Y wishes to submit one NDA (on average) per year]. Benchmarks are also created for small components of much larger activities. For example, a clinical trial or a new drug launch may be divided into hundreds of components, and company standards may be created to serve as goals for the staff to achieve for each individual component, based on industry-wide or company benchmarks. One must be cautious about creating separate benchmarks for subsets of the activities being measured because the information from each of the subsets may not be useful independent of each of the other subset components (i.e., one often needs to look at all of the components of an activity and not single out one or two to measure and assess). For example, looking at the time to data lock after a trial is completed makes sense but not if one were to divide this into five separate components.

On the other hand, creating benchmarks for smaller activities allows measurement of progress when certain major issues are beyond the control of the project team. For example, the goal to “obtain Food and Drug Administration approval” is a huge milestone. You could do your trials on time, have good results, submit a quality NDA on time, and so on; however, if a competitor’s product in the same therapeutic category was just the subject of a number of serious adverse event reports, it is likely that the Food and Drug Administration will ask you to study this new area. Without the smaller benchmarks, the team would be judged as not meeting the benchmark goal of obtaining Food and Drug Administration approval within a certain timeline, when their “failure” was due to reasons beyond their control.


Application of Benchmarks as Goals or Guides

Benchmarks (i.e., standards based on multiple persons’ or a group’s experiences) are used both as goals to achieve on an annual (or other) basis and as guides to help a company achieve its goals. The reasons for creating and using benchmarks are usually laudable. It is desirable to create standards and goals using real-world data on specific activities, behaviors, accomplishments, or practices instead of basing company standards on ideal, hypothetical, subjective, or arbitrary data or opinions that may be biased or inaccurate or may not be based on the most appropriate data. Industry benchmarks are usually created from the averages or ranges of different companies’ experiences.

Oct 2, 2016 | Posted by in GENERAL SURGERY | Comments Off on Creating and Using Benchmarks

Full access? Get Clinical Tree

Get Clinical Tree app for offline access